Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage

Eukaryotic Cell

Volumn 9, Issue 1, 2010, Pages 22-30

  Morales, Miguel A ^a   Pescher, Pascale ^a   Späth, Gerald F ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; PROTOZOAL PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CYTOLOGY; GENETICS; HUMAN; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; MACROPHAGE; METABOLISM; MOUSE; PARASITOLOGY; PATHOGENICITY; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GREEN FLUORESCENT PROTEINS; HUMANS; ISOENZYMES; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS;

LEISHMANIA DONOVANI; LEISHMANIA MAJOR; PROTOZOA;

EID: 75649123785     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00196-09     Document Type: Article

References (46)

1. Barak, E., S. Amin-Spector, E. Gerliak, S. Goyard, N. Holland, and D. Zilberstein. 2005. Differentiation of Leishmania donovani in host-free system: analysis of signal perception and response. Mol. Biochem. Parasitol. 141:99-108.
2. Brook, M., G. Sully, A. R. Clark, and J. Saklatvala. 2000. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett. 483:57-61.
3. Chappuis, F., S. Sundar, A. Hailu, H. Ghalib, S. Rijal, R. W. Peeling, J. Alvar, and M. Boelaert. 2007. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat. Rev. Microbiol. 5:873-882.
4. Cheng, M., V. Sexl, C. J. Sherr, and M. F. Roussel. 1998. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. U.S.A.95:1091-1096.
5. Clayton, C., and M. Shapira. 2007. Post-transcriptional regulation of gene expression in trypanosomes and leishmanias. Mol. Biochem. Parasitol. 156: 93-101.
6. Clayton, C. E. 2002. Life without transcriptional control? From fly to man and back again. EMBO J. 21:1881-1888.
7. da Silva, R., and D. L. Sacks. 1987. Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect. Immun. 55: 2802-2806.
8. Davis, R. J. 1995. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42:459-467.
9. Dean, J. L., M. Brook, A. R. Clark, and J. Saklatvala. 1999. p38 mitogen activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274:264-269.
10. Debrabant, A., M. B. Joshi, P. F. Pimenta, and D. M. Dwyer. 2004. Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics. Int. J. Parasitol. 34:205-217.
11. Dell, K. R., and J. N. Engel. 1994. Stage-specific regulation of protein phosphorylation in Leishmania major. Mol. Biochem. Parasitol. 64:283-292.
12. Desjeux, P. 2004. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27:305-318.
13. Dever, T. E. 2002. Gene-specific regulation by general translation factors. Cell 108:545-556.
14. Domenicali Pfister, D., G. Burkard, S. Morand, C. K. Renggli, I. Roditi, and E. Vassella. 2006. A mitogen-activated protein kinase controls differentiation of bloodstream forms of Trypanosoma brucei. Eukaryot. Cell 5:1126-1135.
15. Dwyer, D. M. 1976. Antibody-induced modulation of Leishmania donovani surface membrane antigens. J. Immunol. 117:2081-2091.
16. Ellis, J., M. Sarkar, E. Hendriks, and K. Matthews. 2004. A novel ERK-like, CRK-like protein kinase that modulates growth in Trypanosoma brucei via an autoregulatory C-terminal extension. Mol. Microbiol. 53:1487-1499.
17. Goyard, S., H. Segawa, J. Gordon, M. Showalter, R. Duncan, S. J. Turco, and S. M. Beverley. 2003. An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans. Mol. Biochem. Parasitol. 130:31-42.
18. Hunter, T. 1998. The role of tyrosine phosphorylation in cell growth and disease. Harvey Lect. 94:81-119.
19. Ivens, A. C., C. S. Peacock, E. A. Worthey, L. Murphy, G. Aggarwal, M. Berriman, E. Sisk, M. A. Rajandream, E. Adlem, R. Aert, A. Anupama, Z. Apostolou, P. Attipoe, N. Bason, C. Bauser, A. Beck, S. M. Beverley, G. Bianchettin, K. Borzym, G. Bothe, C. V. Bruschi, M. Collins, E. Cadag, L. Ciarloni, C. Clayton, R. M. Coulson, A. Cronin, A. K. Cruz, R. M. Davies, J. De Gaudenzi, D. E. Dobson, A. Duesterhoeft, G. Fazelina, N. Fosker, A. C. Frasch, A. Fraser, M. Fuchs, C. Gabel, A. Goble, A. Goffeau, D. Harris, C. Hertz-Fowler, H. Hilbert, D. Horn, Y. Huang, S. Klages, A. Knights, M. Kube, N. Larke, L. Litvin, A. Lord, T. Louie, M. Marra, D. Masuy, K. Matthews, S. Michaeli, J. C. Mottram, S. Muller-Auer, H. Munden, S. Nelson, H. Norbertczak, K. Oliver, S. O'Neil, M. Pentony, T. M. Pohl, C. Price, B. Purnelle, M. A. Quail, E. Rabbinowitsch, R. Reinhardt, M. Rieger, J. Rinta, J. Robben, L. Robertson, J. C. Ruiz, S. Rutter, D. Saunders, M. Schafer, J. Schein, D. C. Schwartz, K. Seeger, A. Seyler, S. Sharp, H. Shin, D. Sivam, R. Squares, S. Squares, V. Tosato, C. Vogt, G. Volckaert, R. Wambutt, T. Warren, H. Wedler, J. Woodward, S. Zhou, W. Zimmermann, D. F. Smith, J. M. Blackwell, K. D. Stuart, B. Barrell, and P. J. Myler. 2005. The genome of the kinetoplastid parasite, Leishmania major. Science 309: 436-442.
20. Kamau, S. W., M. Hurtado, U. U. Muller-Doblies, F. Grimm, and R. Nunez. 2000. Flow cytometric assessment of allopurinol susceptibility in Leishmania infantum promastigote. Cytometry 40:353-360.
21. Kapler, G. M., C. M. Coburn, and S. M. Beverley. 1990. Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol. Cell. Biol. 10:1084-1094.
22. Morales, M. A., O. Renaud, W. Faigle, S. L. Shorte, and G. F. Spath. 2007. Over-expression of Leishmania major MAP kinases reveals stage-specific induction of phosphotransferase activity. Int. J. Parasitol. 37:1187-1199.
23. Morales, M. A., R. Watanabe, C. Laurent, P. Lenormand, J. C. Rousselle, A. Namane, and G. F. Spath. 2008. Phosphoproteomic analysis of Leishmania donovani proand amastigote stages. Proteomics 8:350-363.
24. Mukhopadhyay, N. K., A. K. Saha, J. K. Lovelace, R. Da Silva, D. L. Sacks, and R. H. Glew. 1988. Comparison of the protein kinase and acid phosphatase activities of five species of Leishmania. J. Protozool. 35:601-607.
25. Muller, I. B., D. Domenicali-Pfister, I. Roditi, and E. Vassella. 2002. Stage-specific requirement of a mitogen-activated protein kinase by Trypanosoma brucei. Mol. Biol. Cell 13:3787-3799.
26. Parry, D., D. Mahony, K. Wills, and E. Lees. 1999. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19:1775-1783.
27. Parsons, M., E. A. Worthey, P. N. Ward, and J. C. Mottram. 2005. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi. BMC Genomics 6:127.
28. Pyronnet, S., H. Imataka, A. C. Gingras, R. Fukunaga, T. Hunter, and N. Sonenberg. 1999. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J. 18:270-279.
29. Rotureau, B., M. A. Morales, P. Bastin, and G. F. Spath. 2009. The flagellum-MAP kinase connection in trypanosomatids: a key sensory role in parasite signaling and development? Cell. Microbiol. 11:710-718.
30. Saar, Y., A. Ransford, E. Waldman, S. Mazareb, S. Amin-Spector, J. Plumblee, S. J. Turco, and D. Zilberstein. 1998. Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani. Mol. Biochem. Parasitol. 95:9-20.
31. Sacks, D. L., and P. V. Perkins. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223:1417-1419.
32. Sewing, A., B. Wiseman, A. C. Lloyd, and H. Land. 1997. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5588-5597.
33. Spath, G. F., and S. M. Beverley. 2001. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 99:97-103.
34. Spath, G. F., L. Epstein, B. Leader, S. M. Singer, H. A. Avila, S. J. Turco, and S. M. Beverley. 2000. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. U.S.A.97:9258-9263.
35. Spath, G. F., L. A. Garraway, S. J. Turco, and S. M. Beverley. 2003. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. U.S.A.100: 9536-9541.
36. Spath, G. F., L. F. Lye, H. Segawa, D. L. Sacks, S. J. Turco, and S. M. Beverley. 2003. Persistence without pathology in phosphoglycan-deficient Leishmania major. Science 301:1241-1243.
37. Titus, R. G., F. J. Gueiros-Filho, L. A. de Freitas, and S. M. Beverley. 1995. Development of a safe live Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. U.S.A.92:10267-10271.
38. Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545-555.
39. Titus, R. G., I. Muller, P. Kimsey, A. Cerny, R. Behin, R. M. Zinkernagel, and J. A. Louis. 1991. Exacerbation of experimental murine cutaneous leishmaniasis with CD4 Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hyper sensitivity. Eur. J. Immunol. 21:559-567.
40. Tolson, D. L., S. J. Turco, and T. W. Pearson. 1990. Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani. Infect. Immun. 58:3500-3507.
41. Wang, Q., I. M. Melzer, M. Kruse, C. Sander-Juelch, and M. Wiese. 2005. LmxMPK4, a mitogen-activated protein (MAP) kinase homologue essential for promastigotes and amastigotes of Leishmania mexicana. Kinetoplastid Biol. Dis. 4:6.
42. Wiese, M. 1998. A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host. EMBO J. 17:2619-2628.
43. Wiese, M. 2007. Leishmania MAP kinases-familiar proteins in an unusual context. Int. J. Parasitol. 37:1053-1062.
44. Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5598-5611.
45. Wright, J. H., E. Munar, D. R. Jameson, P. R. Andreassen, R. L. Margolis, R. Seger, and E. G. Krebs. 1999. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc. Natl. Acad. Sci. U.S.A.96:11335-11340.
46. Zilberstein, D., and M. Shapira. 1994. The role of pH and temperature in the development of Leishmania parasites. Annu. Rev. Microbiol. 48:449-470.